| 59 |
HNF4alpha suppression leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
461: Suppression, HNF4alpha
|
None
|
|
|
| 4 |
Ecdysone receptor agonism leading to mortality via suppression of Ftz-f1 |
Knut Erik Tollefsen |
BY-SA |
103: Increase, Ecdysone receptor hyperactivation
|
2 AOs
|
|
|
| 19 |
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) |
Mukesh Patel |
Open for adoption |
26: Antagonism, Androgen receptor
|
337: N/A, Impairment of reproductive capacity
|
|
|
| 26 |
Calcium-mediated neuronal ROS production and energy imbalance |
Lyle Burgoon |
Open for adoption |
51: Inhibition, Ca++ ATPase
|
1392: Increase, Oxidative Stress
|
|
|
| 28 |
Cyclooxygenase inhibition leading reproductive failure |
Dan Villeneuve |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
253: N/A, Reproductive failure
|
|
|
| 29 |
Estrogen receptor agonism leading to reproductive dysfunction |
Undefined |
BY-SA |
111: Agonism, Estrogen receptor
|
4 AOs
|
|
|
| 32 |
Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors |
Undefined |
BY-SA |
None
|
None
|
|
|
| 33 |
Kidney toxicity induced by activation of 5HT2C |
Kevin Crofton |
Open for adoption |
9: Activation, 5HT2c
|
759: Increased, Kidney Failure
|
|
|
| 34 |
LXR activation leading to hepatic steatosis |
Undefined |
BY-SA |
2 MIEs
|
345: N/A, Liver Steatosis
|
|
|
| 36 |
Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis |
Michelle Angrish |
BY-SA |
3 MIEs
|
459: Increase, Liver steatosis
|
|
|
| 52 |
ER agonism leading to skewed sex ratios due to altered sexual differentiation in males |
Undefined |
BY-SA |
111: Agonism, Estrogen receptor
|
417: skewed, sex ratio
|
|
|
| 53 |
ER agonism leading to reduced survival due to renal failure |
Undefined |
BY-SA |
111: Agonism, Estrogen receptor
|
None
|
|
|
| 57 |
AhR activation leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
18: Activation, AhR
|
459: Increase, Liver steatosis
|
|
|
| 58 |
NR1I3 (CAR) suppression leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
4 MIEs
|
459: Increase, Liver steatosis
|
|
|
| 74 |
Modulation of Adult Leydig Cell Function Subsequent to Hypermethylation in the Fetal Testis |
Undefined |
BY-SA |
662: Decreased testosterone by the fetal Leydig cells, Hypermethylation in the fetal testis
|
543: Decreased fertility in the adult, Decreased sperm quantity and/or quality in the adult testis
|
|
|
| 60 |
NR1I2 (Pregnane X Receptor, PXR) activation leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
245: Activation, PXR/SXR
|
459: Increase, Liver steatosis
|
|
|
| 61 |
NFE2L2/FXR activation leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
2 MIEs
|
459: Increase, Liver steatosis
|
|
|
| 62 |
AKT2 activation leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
486: systemic inflammation leading to hepatic steatosis
|
459: Increase, Liver steatosis
|
|
|
| 63 |
Cyclooxygenase inhibition leading to reproductive dysfunction |
Dalma Martinovic-Weigelt |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 64 |
Glucocorticoid Receptor (GR) Mediated Adult Leydig Cell Dysfunction Leading to Decreased Male Fertility |
Undefined |
BY-SA |
494: Glucocorticoid Receptor Agonist, Activation
|
406: decreased, Fertility
|
|
|
| 66 |
Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis |
Undefined |
BY-SA |
2 MIEs
|
505: Decreased sperm quantity / quality in the adult, Decreased fertility
|
|
|
| 67 |
Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis |
Undefined |
BY-SA |
2 MIEs
|
505: Decreased sperm quantity / quality in the adult, Decreased fertility
|
|
|
| 68 |
Modulation of Adult Leydig Cell Function Subsequent to Alterations in the Fetal Testis Protome |
Undefined |
BY-SA |
661: Decreased testosterone by the fetal Leydig cells, Alterations in the fetal testis proteome
|
505: Decreased sperm quantity / quality in the adult, Decreased fertility
|
|
|
| 69 |
Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell |
Undefined |
BY-SA |
3 MIEs
|
646: Decreased Cholesterol, Decreased sperm quantity and/or quality in the adult testis
|
|
|
| 70 |
Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell |
Undefined |
BY-SA |
640: Decreased steroidogenesis, Proteomic alterations in the adult Leydig cell
|
520: Decreased sperm quantity or quality in the adult, Decreased fertility
|
|
|